Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Coty Inc is a household & personal products business based in the US. Coty shares (COTY) are listed on the NYSE and all prices are listed in US Dollars. Coty employs 11,430 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$8.32|
|52-week range||$2.65 - $10.49|
|50-day moving average||$8.58|
|200-day moving average||$8.84|
|Wall St. target price||$11.07|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.40|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-0.36%|
|1 month (2021-08-24)||1.84%|
|3 months (2021-06-24)||-11.77%|
|6 months (2021-03-24)||2.46%|
|1 year (2020-09-24)||200.36%|
|2 years (2019-09-24)||-20.15%|
|3 years (2018-09-24)||13.03|
|5 years (2016-09-23)||23.39|
Valuing Coty stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Coty's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Coty's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8241. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Coty's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Coty's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $745.5 million.
The EBITDA is a measure of a Coty's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.6 billion|
|Operating margin TTM||3.46%|
|Gross profit TTM||$2.8 billion|
|Return on assets TTM||0.66%|
|Return on equity TTM||-1.65%|
|Market capitalisation||$6.8 billion|
TTM: trailing 12 months
There are currently 15.5 million Coty shares held short by investors – that's known as Coty's "short interest". This figure is 9% down from 17.0 million last month.
There are a few different ways that this level of interest in shorting Coty shares can be evaluated.
Coty's "short interest ratio" (SIR) is the quantity of Coty shares currently shorted divided by the average quantity of Coty shares traded daily (recently around 7.6 million). Coty's SIR currently stands at 2.05. In other words for every 100,000 Coty shares traded daily on the market, roughly 2050 shares are currently held short.
However Coty's short interest can also be evaluated against the total number of Coty shares, or, against the total number of tradable Coty shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Coty's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Coty shares in existence, roughly 20 shares are currently held short) or 0.0507% of the tradable shares (for every 100,000 tradable Coty shares, roughly 51 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Coty.
Find out more about how you can short Coty stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Coty.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32.45
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Coty's overall score of 32.45 (as at 12/31/2018) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Coty is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 16.02/100
Coty's environmental score of 16.02 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Coty is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 12.11/100
Coty's social score of 12.11 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Coty is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 9.83/100
Coty's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Coty is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Coty scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Coty has, for the most part, managed to keep its nose clean.
|Total ESG score||32.45|
|Total ESG percentile||65.1|
|Environmental score percentile||3|
|Social score percentile||3|
|Governance score percentile||3|
|Level of controversy||2|
We're not expecting Coty to pay a dividend over the next 12 months.
Over the last 12 months, Coty's shares have ranged in value from as little as $2.65 up to $10.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Coty's is 2.5104. This would suggest that Coty's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Coty Inc. , together with its subsidiaries, engages in the manufacture, marketing, distribution, and sale of beauty products worldwide. The company provides prestige fragrances, skin care, and color cosmetics products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Alexander McQueen, Burberry, Bottega Veneta, Calvin Klein, Cavalli, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lacoste, Lancaster, Marc Jacobs, Miu Miu, Nikos, philosophy, Kim Kardashian West, and Tiffany & Co. brands. It also offers mass color cosmetics, fragrance, skin care, and body care products primarily through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, Stetson, and 007 James Bond brands. Coty Inc. also sells its products through third-party distributors to approximately 150 countries and territories.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.